3-deazaguanine has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khwaja, TA; Mian, AM | 1 |
| Khwaja, TA | 1 |
| Besserer, JA; Boritzki, TJ; Fry, DW; Jackson, RC; Leopold, WR; Pattison, IC | 1 |
3 other study(ies) available for 3-deazaguanine and Adenocarcinoma
| Article | Year |
|---|---|
synthesis and antitumor activity of 2-deoxyribofuranosides of 3-deazaguanine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Deoxyribose; Female; Guanosine; Indicators and Reagents; Isomerism; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Structure-Activity Relationship | 1983 |
3-deazaguanine, a candidate drug for the chemotherapy of breast carcinomas?
Topics: Adenocarcinoma; Animals; Antimetabolites; Breast Neoplasms; Cell Line; Female; Guanine; Leukemia, Experimental; Mice; Neoplasm Transplantation; Rats | 1982 |
Dezaguanine mesylate: a new antipurine antimetabolite.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Survival; Cells, Cultured; DNA, Neoplasm; Drug Evaluation; Guanine; Humans; Kinetics; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Purines; Time Factors | 1985 |